Las Vegas, NV -- (SBWIRE) -- 12/09/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: LeapFrog Enterprises, Inc. (NYSE:LF), Unisys Corporation (NYSE:UIS), Array Biopharma Inc (NASDAQ:ARRY), Responsys Inc (NASDAQ:MKTG)
LeapFrog Enterprises, Inc. (NYSE:LF) managed to keep its fall at -0.23% on below -normal volume of 1.29M shares. The stock settled at $8.57 after floating in a range of $8.55 to $8.80. Its latest price has reached market capitalization of $590.64 million. Its 52-week range has been $7.40 to $11.95. LeapFrog Enterprises, Inc. (LeapFrog) is a developer of educational entertainment for children. The Company’s product portfolio consists of multimedia learning platforms and related content and learning toys.
Has LF Found The Bottom and Ready To Move Up? Find Out Here
Unisys Corporation (NYSE:UIS) traded up on a volume of 1.29 million, higher than its standard daily volume. Shares have gained 9.09% to $30. Over the last twelve months, the stock has gained 70.94% and faced a worst price of $15.68. Unisys Corporation is a worldwide information technology (IT) company. The Company provides a portfolio of IT services, software, and technology that solves mission-critical problems for clients. The Company specializes in helping clients secure their operations, increase the efficiency and utilization of their data centers, enhances support to their end users and constituents, and modernize their enterprise applications. Its services and solutions include outsourcing services, systems integration and consulting services, infrastructure services, maintenance services, and high-end server technology. Unisys serves commercial organizations and government agencies throughout the world. The Company operates in two business segments: Services and Technology.
For How Long UIS’s Gloss will Attract Investors? Find out via this report
Array Biopharma Inc (NASDAQ:ARRY) settled 0.34% higher at $5.98 on below -normal volume of 1.28M shares during the last trading day. The stock has its 12-month high at $7.10 and 52-week low price was $3.41. It traded in a range of $5.85 to $6.05 during the last trading day. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways.
Why Should Investors Buy ARRY After the Recent Fall? Just Go Here and Find Out
In the last trading session, Responsys Inc (NASDAQ:MKTG) was up on high volume, trading at a volume of 1.27M shares versus its average daily volume of 383,055.00 shares. At $19.90, the stock has attained market capitalization of $1.02 billion. Responsys, Inc. (Responsys) is a provider of on-demand software and professional services. The Company’s offering, the Responsys Interact Suite, provides marketers with a range of integrated applications to create, execute, optimize and automate marketing campaigns across the interactive channels, such as e-mail, mobile, social and the Web. The Responsys Interact Suite is a software-as-a-service (SaaS) solution platform.
Will MKTG Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. https://www.sbwire.com/account/distribute/release/manage/analysis/?id=405167/a> does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/" rel="nofollow" href="http://www.pennystockearnings.com/">PennyStockEarnings.com<https://www.sbwire.com/account/distribute/release/manage/analysis/?id=405167/a> does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/>
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)